Stay updated on Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added a new publication citation to the Publications section (Dermatol Ther, 2026 Mar 16) and updated the page revision to v3.5.0 (from v3.4.3).
    Difference
    0.1%
    Check dated 2026-03-18T18:03:15.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision: v3.4.3 implemented, replacing v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T14:45:01.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page layout and sections appear reorganized in the new screenshot. No core study details, eligibility criteria, outcomes, or results have been added or removed.
    Difference
    0.1%
    Check dated 2026-03-04T10:43:12.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page shows a site revision indicator (Revision: v3.4.2) and removal of prior notices about funding and operating status, with no change to the study details or core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:50:22.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding and the NIH Clinical Center's status. Updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T05:53:22.000Z thumbnail image
  9. Check
    74 days ago
    Change Detected
    Summary
    Added a glossary toggle and new metadata lines: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed the previous lines: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T04:13:37.000Z thumbnail image

Stay in the know with updates to Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tildrakizumab for Chronic Plaque Psoriasis Clinical Trial page.